Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
about
Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthmaAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenRegular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse eventsAddition to inhaled corticosteroids of long-acting beta 2-agonists versus anti-leukotrienes for chronic asthmaAddition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and childrenAddition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and childrenRegular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse eventsLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaAddition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adultsAdd-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive reviewApproach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranRevisiting early intervention in adult asthmaAntileukotriene agents for the treatment of lung diseaseAllergic rhinitis: evidence for impact on asthmaAllergic rhinitis and asthma: inflammation in a one-airway condition.Role of Leukotrienes and Leukotriene Modifiers in Asthma.Comparing the efficacy and influence on the quality of life of three classes of drugs used in bronchial asthma - a prospective study.Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.Risk factors for montelukast treatment failure in step-down therapy for controlled asthmaPharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues.Scientific respiratory symposium, paris june 2010Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness.A review of montelukast in the treatment of asthma and allergic rhinitis.Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly.Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling studyRecent developments in asthma managementMontelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial).Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)Montelukast in asthma: a review of its efficacy and place in therapy.The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1Stratified approaches to the treatment of asthma.Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot studyLong-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.Evaluating combination therapies for asthma: pros, cons, and comparative benefits.Pharmacotherapy of asthma: regular treatment or on demand?Leukotriene modifiers in the treatment of asthma in children.Montelukast in the treatment of asthma as a systemic disease.Effects of asthma treatment: the present and future.
P2860
Q24197585-EA1DFE04-77A9-4215-BFEC-C5E5BA23A8E5Q24197682-F678BE30-9CB6-4C6A-AAF1-F72F363835BAQ24199079-1F1BBD6A-C030-4922-9EE2-071A875F5311Q24200999-EA344943-7B21-4DE6-9C62-37A7B5A3B980Q24234499-1C87403E-37CA-4485-8CE0-38F57432461BQ24235303-E574DFCF-2371-443B-8D03-6C1CE9EB420FQ24240464-7D785704-B7B3-4E67-83EF-C8B2001FBA22Q24241740-33979F63-6DE4-43BE-92CC-5012A493A9F5Q24244152-61412E3E-20AA-4473-A8A8-58789881B724Q24245719-C7A8FDF1-8FDC-4B4F-96A0-E6952146B547Q24794527-63819C1B-1103-4442-A135-D8D574DFBB7DQ26777154-695DA828-7400-484E-9F69-1678C0E4C056Q28071831-677A8306-75E9-4B1A-8A6A-1729CFC706F3Q28293842-9A93ADE7-BBA5-4031-9B87-22EDDA0B157DQ33265228-C6389CA1-1748-42E3-BA7A-B3DEF2486739Q33265229-228ABFF4-0E11-4DC7-BD17-845A62D8F1C1Q33664150-8227D786-0B2A-4D34-8E3C-F98639698959Q34479734-645D1AAE-CD35-4D7A-97A9-0D864F3420D5Q34693644-28D295B9-186A-414B-96F5-CB494982E7C3Q34778001-5FCF3607-A1D0-41BA-A2D5-303EDEA867ADQ35113606-D213A84B-6877-4BF3-AC98-060FD9AAC35AQ35117833-B2667DCA-8BAF-48D3-95C6-92AC243895EEQ35523534-5231EE25-B577-4DDA-9D87-FDE0CB5E5C2BQ35688199-B99DFC34-FC34-4027-9639-99AC57BAF383Q35765263-E14A11DC-9BDD-463D-98FC-D5A9E0991F47Q35798055-4F08585D-1CEE-47D5-9C48-1D7ECF5E6C80Q36067978-950FCC46-F502-4377-988B-4C137ECD2B1AQ36364530-581938B3-E179-48ED-8650-833D657E0B3DQ36364534-4726E743-5130-40A1-A972-79767E663AF3Q36443703-47D75073-5CCE-4A84-9C12-7A29F92FBAF7Q36929333-A620CD35-E2ED-4ECF-A8AF-7533C9DF0FE3Q37064755-9E3452C1-41FE-414D-B5BA-07DB013C402AQ37077214-C624E0F9-153B-4988-A798-ABC1AE3039BBQ37137128-C828C4A4-2AA1-44C8-839C-68DA4C9994C0Q37181742-61EE3EB9-CE48-42E4-97F6-F4326CEC1FB4Q37362610-41D2C689-14D0-46A2-987F-294DC2BBD281Q37578103-225F8478-4045-4815-BBE4-8D61992CC1C3Q37613312-0F7D537D-76A5-4873-8BB5-83C299453DD9Q37754612-087102CD-615F-47BF-8AE9-187C9A5F7380Q37755242-F144EE77-6064-40D3-AEF5-AE7272BF825D
P2860
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Montelukast and fluticasone co ...... randomised, comparative trial
@ast
Montelukast and fluticasone co ...... randomised, comparative trial
@en
type
label
Montelukast and fluticasone co ...... randomised, comparative trial
@ast
Montelukast and fluticasone co ...... randomised, comparative trial
@en
prefLabel
Montelukast and fluticasone co ...... randomised, comparative trial
@ast
Montelukast and fluticasone co ...... randomised, comparative trial
@en
P2093
P2860
P50
P356
P1433
P1476
Montelukast and fluticasone co ...... randomised, comparative trial
@en
P2093
Andrew P Greening
Cesar Picado
Jean Bousquet
Jonathan A Leff
Joris Menten
Leonardo M Fabbri
Peter G Polos
S Balachandra Dass
P2860
P356
10.1136/BMJ.327.7420.891
P407
P577
2003-10-01T00:00:00Z